Granulocyte-monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis.
CONCLUSIONS: Combination of GMA and anti-tumor necrosis factor is a safe and effective treatment after the loss of response to this biologic agents, with a significant decrease of the clinical disease activity and biomarkers, in a population with limited therapeutic alternatives.
PMID: 30982369 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
More News: Colectomy | Gastroenterology | Humira | Inflammatory Bowel Disease | PET Scan | Remicade | Study | Ulcerative Colitis